Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 350 | 790 | 3,480 | 2,810 | 30 |
| Marketable Securities | 3,270 | 2,870 | 0 | 0 | 0 |
| Receivables | 0 | 70 | 0 | 0 | 0 |
| Other current assets | 300 | 70 | 10 | 10 | 30 |
| TOTAL | $3,920 | $3,800 | $3,490 | $2,820 | $60 |
| Non-Current Assets | |||||
| PPE Net | N/A | 140 | N/A | N/A | N/A |
| Investments And Advances | 500 | 990 | 0 | 0 | 0 |
| Other Non-Current Assets | 387 | 347 | 277 | 237 | 197 |
| TOTAL | $887 | $1,477 | $277 | $237 | $197 |
| Total Assets | $4,880 | $5,230 | $3,850 | $3,140 | $340 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 250 | 80 | 80 | 20 | 120 |
| Accrued Expenses | 240 | 290 | 160 | 410 | 310 |
| TOTAL | $490 | $370 | $250 | $430 | $840 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 70 | 60 | 50 | 50 | 40 |
| TOTAL | $70 | $60 | $50 | $50 | $40 |
| Total Liabilities | $570 | $440 | $300 | $490 | $890 |
| Shareholders' Equity | |||||
| Common Shares | 110 | 110 | 100 | 100 | 70 |
| Retained earnings | -7,940 | -7,430 | -7,080 | -6,590 | -5,990 |
| Other shareholders' equity | 10 | -50 | -90 | -80 | -80 |
| TOTAL | $4,310 | $4,780 | $3,540 | $2,640 | $-550 |
| Total Liabilities And Equity | $4,880 | $5,220 | $3,840 | $3,130 | $340 |